Phase II Progress Report

Self-organization via Active Exploration in Robotic Applications Phase II: Hybrid Hardware Prototype Final Progress Report

Design issues of randomized phase II trials and a proposal for phase II screening trials.

Future progress in improving cancer therapy can be expedited by better prioritization of new treatments for phase III evaluation. Historically, phase II trials have been key components in the prioritization process. There has been a long-standing interest in using phase II trials with randomization against a standard-treatment control arm or an additional experimental arm to provide greater ass...

A progress - Report on 18 years of continuous Measles Vaccination in Rural Areas of Iran

Treatment of a Child with Refractory Acute Myeloid Leukemia with Humanized Anti-CD33 Monoclonal Antibody: A Case Report and Review of Drug Development

Background: The induction chemotherapy regimen for acute myeloid leukemia has evolved as once induction is completed patients progress through the consolidation phase and achieve remission in 76% of cases. For patients with relapsed or refractory disease, alternative chemotherapy agents are available. Monoclonal antibody therapy with biological agents, such as the immunotoxin gemtuzumab ozog...

A new photon recoil experiment: towards a determination of the fine structure constant

We report on progress towards a measurement of the fine structure constant α to an accuracy of 5 × 10 or better by measuring the ratio h/mCs of the Planck constant h to the mass of the cesium atom mCs. Compared to similar experiments, ours is improved in three significant ways: (i) simultaneous conjugate interferometers, (ii) multi-photon Bragg diffraction between same internal states, and (iii...